BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25664657)

  • 21. Attention-Deficit/Hyperactivity Disorder, Trait Impulsivity, and Externalizing Behavior in a Longitudinal Sample.
    Ahmad SI; Hinshaw SP
    J Abnorm Child Psychol; 2017 Aug; 45(6):1077-1089. PubMed ID: 27838891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Childhood and current ADHD symptom dimensions are associated with more severe cannabis outcomes in college students.
    Bidwell LC; Henry EA; Willcutt EG; Kinnear MK; Ito TA
    Drug Alcohol Depend; 2014 Feb; 135():88-94. PubMed ID: 24332802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lifetime criminality among boys with attention deficit hyperactivity disorder: a prospective follow-up study into adulthood using official arrest records.
    Mannuzza S; Klein RG; Moulton JL
    Psychiatry Res; 2008 Sep; 160(3):237-46. PubMed ID: 18707766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peer rejection and friendships in children with Attention-Deficit/Hyperactivity Disorder: contributions to long-term outcomes.
    Mrug S; Molina BS; Hoza B; Gerdes AC; Hinshaw SP; Hechtman L; Arnold LE
    J Abnorm Child Psychol; 2012 Aug; 40(6):1013-26. PubMed ID: 22331455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations between childhood ADHD, gender, and adolescent alcohol and marijuana involvement: A causally informative design.
    Elkins IJ; Saunders GRB; Malone SM; Keyes MA; McGue M; Iacono WG
    Drug Alcohol Depend; 2018 Mar; 184():33-41. PubMed ID: 29402677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association Between Stimulant Treatment and Substance Use Through Adolescence Into Early Adulthood.
    Molina BSG; Kennedy TM; Howard AL; Swanson JM; Arnold LE; Mitchell JT; Stehli A; Kennedy EH; Epstein JN; Hechtman LT; Hinshaw SP; Vitiello B
    JAMA Psychiatry; 2023 Sep; 80(9):933-941. PubMed ID: 37405756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subthreshold and threshold attention deficit hyperactivity disorder symptoms in childhood: psychosocial outcomes in adolescence in boys and girls.
    Norén Selinus E; Molero Y; Lichtenstein P; Anckarsäter H; Lundström S; Bottai M; Hellner Gumpert C
    Acta Psychiatr Scand; 2016 Dec; 134(6):533-545. PubMed ID: 27714770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects.
    Molina BSG; Flory K; Hinshaw SP; Greiner AR; Arnold LE; Swanson JM; Hechtman L; Jensen PS; Vitiello B; Hoza B; Pelham WE; Elliott GR; Wells KC; Abikoff HB; Gibbons RD; Marcus S; Conners CK; Epstein JN; Greenhill LL; March JS; Newcorn JH; Severe JB; Wigal T
    J Am Acad Child Adolesc Psychiatry; 2007 Aug; 46(8):1028-1040. PubMed ID: 17667481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding desisting and persisting forms of delinquency: the unique contributions of disruptive behavior disorders and interpersonal callousness.
    Byrd AL; Loeber R; Pardini DA
    J Child Psychol Psychiatry; 2012 Apr; 53(4):371-80. PubMed ID: 22176342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inattention and hyperactivity/impulsivity among children with attention-deficit/hyperactivity-disorder, autism spectrum disorder, and intellectual disability.
    McClain MB; Hasty Mills AM; Murphy LE
    Res Dev Disabil; 2017 Nov; 70():175-184. PubMed ID: 28957735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early substance use in the pathway from childhood attention-deficit/hyperactivity disorder (ADHD) to young adult substance use: Evidence of statistical mediation and substance specificity.
    Howard AL; Kennedy TM; Mitchell JT; Sibley MH; Hinshaw SP; Arnold LE; Roy A; Stehli A; Swanson JM; Molina BSG
    Psychol Addict Behav; 2020 Mar; 34(2):281-292. PubMed ID: 31886682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.
    Nasser A; Hull JT; Chaturvedi SA; Liranso T; Odebo O; Kosheleff AR; Fry N; Cutler AJ; Rubin J; Schwabe S; Childress A
    CNS Drugs; 2022 Aug; 36(8):897-915. PubMed ID: 35896943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substance use and delinquency among adolescents with childhood ADHD: the protective role of parenting.
    Walther CA; Cheong J; Molina BS; Pelham WE; Wymbs BT; Belendiuk KA; Pedersen SL
    Psychol Addict Behav; 2012 Sep; 26(3):585-98. PubMed ID: 22329747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three-year latent class trajectories of attention-deficit/hyperactivity disorder (ADHD) symptoms in a clinical sample not selected for ADHD.
    Arnold LE; Ganocy SJ; Mount K; Youngstrom EA; Frazier T; Fristad M; Horwitz SM; Birmaher B; Findling R; Kowatch RA; Demeter C; Axelson D; Gill MK; Marsh L
    J Am Acad Child Adolesc Psychiatry; 2014 Jul; 53(7):745-60. PubMed ID: 24954824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure and diagnosis of adult attention-deficit/hyperactivity disorder: analysis of expanded symptom criteria from the Adult ADHD Clinical Diagnostic Scale.
    Kessler RC; Green JG; Adler LA; Barkley RA; Chatterji S; Faraone SV; Finkelman M; Greenhill LL; Gruber MJ; Jewell M; Russo LJ; Sampson NA; Van Brunt DL
    Arch Gen Psychiatry; 2010 Nov; 67(11):1168-78. PubMed ID: 21041618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substance use through adolescence into early adulthood after childhood-diagnosed ADHD: findings from the MTA longitudinal study.
    Molina BSG; Howard AL; Swanson JM; Stehli A; Mitchell JT; Kennedy TM; Epstein JN; Arnold LE; Hechtman L; Vitiello B; Hoza B
    J Child Psychol Psychiatry; 2018 Jun; 59(6):692-702. PubMed ID: 29315559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heavy alcohol use in early adulthood as a function of childhood ADHD: developmentally specific mediation by social impairment and delinquency.
    Molina BSG; Walther CAP; Cheong J; Pedersen SL; Gnagy EM; Pelham WE
    Exp Clin Psychopharmacol; 2014 Apr; 22(2):110-121. PubMed ID: 24611838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD.
    Biederman J
    J Clin Psychiatry; 2003; 64 Suppl 11():3-8. PubMed ID: 14529323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The course of attention deficit hyperactivity disorder (ADHD) over the life span].
    Koumoula A
    Psychiatriki; 2012 Jun; 23 Suppl 1():49-59. PubMed ID: 22796973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Daily, but not occasional, cannabis use is selectively associated with more impulsive delay discounting and hyperactive ADHD symptoms in binge-drinking young adults.
    Petker T; Ferro M; Van Ameringen M; Murphy J; MacKillop J
    Psychopharmacology (Berl); 2021 Jul; 238(7):1753-1763. PubMed ID: 33638699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.